These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 8266924)
21. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis. Kario K; Matsuo T Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090 [TBL] [Abstract][Full Text] [Related]
22. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases]. Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516 [TBL] [Abstract][Full Text] [Related]
23. Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns. Aoki K; Aikawa N; Sekine K; Yamazaki M; Mimura T; Urano T; Takada A Burns; 2001 Sep; 27(6):569-75. PubMed ID: 11525850 [TBL] [Abstract][Full Text] [Related]
24. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction. Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093 [TBL] [Abstract][Full Text] [Related]
25. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation. Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737 [TBL] [Abstract][Full Text] [Related]
26. [Clinical application of laboratory diagnosis: leukemia and DIC]. Deguchi K; Zhao LJ; Shirakawa S Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571 [TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of thrombin-antithrombin III complex and plasmin-alpha 2 plasmin inhibitor complex in chronic liver diseases]. Ohmoto K; Yamamoto S; Ideguchi S; Yamamoto R; Takatori K; Ohumi T; Hino K; Hirano Y Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1837-45. PubMed ID: 2147451 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC. Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318 [TBL] [Abstract][Full Text] [Related]
29. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations. Yamada S; Asakura H Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341 [TBL] [Abstract][Full Text] [Related]
30. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group. Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656 [TBL] [Abstract][Full Text] [Related]
31. Hemostatic study before onset of disseminated intravascular coagulation. Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi A; Mori Y; Deguchi K Am J Hematol; 1993 Jul; 43(3):190-4. PubMed ID: 8352234 [TBL] [Abstract][Full Text] [Related]
32. Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis. López-Aguirre Y; Páramo JA Thromb Res; 1999 Apr; 94(2):95-101. PubMed ID: 10230894 [TBL] [Abstract][Full Text] [Related]
33. [Analysis of hemostatic abnormality in various disease using molecular-I. Liver disease]. Shimazu C; Fukuda T; Yugeta N; Yasuda K; Wakasugi K; Tahara C; Miyajima Y; Kazama M Rinsho Byori; 1991 Mar; 39(3):295-301. PubMed ID: 1828841 [TBL] [Abstract][Full Text] [Related]
34. Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator. Takahashi H; Ito S; Hanano M; Wada K; Niwano H; Seki Y; Shibata A Am J Hematol; 1992 Sep; 41(1):32-9. PubMed ID: 1323930 [TBL] [Abstract][Full Text] [Related]
35. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia. Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455 [TBL] [Abstract][Full Text] [Related]
36. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio. Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720 [TBL] [Abstract][Full Text] [Related]
37. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691 [TBL] [Abstract][Full Text] [Related]
38. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication. Tohgi H; Takahashi H; Chiba K; Tamura K Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551 [TBL] [Abstract][Full Text] [Related]
39. Posttrauma coagulation and fibrinolysis. Gando S; Tedo I; Kubota M Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358 [TBL] [Abstract][Full Text] [Related]
40. Performance evaluation of thrombomodulin, thrombin-antithrombin complex, plasmin-α2-antiplasmin complex, and t-PA: PAI-1 complex. Chen Q; Shou W; Wu W; Wang G; Cui W J Clin Lab Anal; 2019 Jul; 33(6):e22913. PubMed ID: 31090232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]